It can be speculated that with the increased of sPD-L1, more sPD-L1 bound to PD-1 on the surface of activated lymphocytes, which limited the activation and proliferation of T lymphocytes, leading to the killing effect of breast cancer cells on immune cells [37]. The gene discussed is SPDL1; the disease is breast carcinoma.